Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Steve Nissen, Chief Academic Officer, Cleveland Clinic Miller Family Heart, Vascular & Thoracic Institute talks about three trials presented at the 2020 AHA Scientific Sessions: the STRENGTH trial (omega 3 fatty acid’s impact on cardiovascular events) ; STOP AF trial (medication vs. ablation in treating patients with new onset atrial fibrillation); and the RHAPSODY trial (randomized trial of rilonacept in the treatment of recurrent pericarditis). He also provides his take on the SAMSON trial (symptoms related to statins vs. placebo) and TIPS-3 (an international poly-pill study).

Dr. Eric Roselli and Dr. Amit Goyal discuss cardiac arrest and deep dive on a patient rescue.

Dr. Allan Klein, Director of Cleveland Clinic’s Pericardial Disease Center, provides the results of the RHAPSODY trial, a pivotal Phase 3 trial that evaluated rilonacept, an interleukin 1-α and 1-β inhibitor, compared with placebo among patients with recurrent pericarditis. Study design and findings are provided, as well as implications for future care for patients with pericarditis.

Dr. Eric Roselli and Dr. Amit Goyal discuss 2000 Heart Transplants at the Cleveland Clinic.

Many thoracic surgery cases are now being performed using robotically assisted surgery. Dr. Sudish Murthy and Dr. Usman Ahmad discuss how the robot is used and the types of procedures that benefit from this minimally invasive approach.

The ACC CVD in Women Committee published a summary of recommendations for primary prevention of cardiovascular disease specific to women. Dr. Leslie Cho, Director of the Women’s Cardiovascular Center and Co-Section Head, Preventive Cardiology, discusses what clinicians should know about the updated guidelines. She addresses unique risk factors that pertain to women, as well as how traditional risk factors can be different for women in presentation and treatment.

Jerry Estep, MD, Section Head of Heart Failure and Transplantation, discusses a Tall Rounds® on the topic of Cardiogenic Shock, focusing on the team approach that is required to provide optimal care. Featuring a presentation from Venu Menon MD, Section Head of Clinical Cardiology, defining cardiogenic shock and including lessons learned from the SHOCK trial and classifications of shock impact on treatment and outcomes.

What is involved in state of the art coronary artery bypass surgery? Dr. Faisal Bakaeen, Director of the Coronary Artery Bypass Surgery Center talks about the long history of bypass surgery at Cleveland Clinic and goals for CABG surgery such as our multi-arterial strategy [including the thoracic artery, bilateral thoracic artery and use of other arteries] and the importance of surgical technique and patient selection for best outcomes. Dr. Bakaeen provides study data regarding off pump CABG and considerations to enhance quality and safety outcomes for patients undergoing CABG surgery, including high risk bypass surgery.

Dr. Eric Roselli and Dr. Amit Goyal discuss COVID-19 and Early Insights into Cardiovascular Issues.

Dr. Eric Roselli and Dr. Amit Goyal discuss digital health and the care of the cardiovascular patient.